z-logo
open-access-imgOpen Access
High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study
Author(s) -
Philip Bruggmann,
Oliver Senn,
Anja Frei,
Milo A. Puhan,
Jan Fehr,
Luis Falcato
Publication year - 2022
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2022.w30122
Subject(s) - medicine , seroprevalence , population , cross sectional study , confidence interval , demography , epidemiology , socioeconomic status , immunology , antibody , environmental health , serology , pathology , sociology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here